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During colonization of the cystic fibrosis airway Pseudomonas aeruginosa
converts from non-mucoid to a mucoid phenotype, characterized by the production of
the exopolysaccharide alginate. Alginate production has been shown to enhance
survival by promoting biofilm formation, evading complement killing, and resisting
phagocytosis. The mechanism by which alginate protects P. aeruginosa from
phagocytosis is unclear. To investigate the role of alginate in the inhibition of
phagocytosis, a human monocytic cell line (THP-1) and a murine alveolar macrophage
cell line (MH-S) were used to determine the effects of alginate on macrophage binding,

signaling, and phagocytosis. Phagocytosis assays using the mucoid cystic fibrosis
clinical isolate FRD1, and its non-mucoid isogenic algD mutant FRD1131, revealed that
alginate inhibits opsonic and non-opsonic phagocytosis. The inhibitory effect of alginate
production is intrinsic to the bacteria as exogenous alginate was unable to protect nonmucoid FRD1131 from phagocytosis. Decreased binding of FRD1 compared to
FRD1131 was also demonstrated by using the actin polymerization inhibitor
cytochalasin D to inhibit phagocytosis. Furthermore, studies using blocking antibodies to
CD11b and CD14 found that both of these receptors were important for the
phagocytosis of FRD, and it is likely that these receptors are blocked by alginate.
Alginate production by P. aeruginosa may reduce lipid raft formation, however, it was
not found to affect acid sphingomyelinase activity, which is important for ceramide
formation within the lipid raft. Decreased binding led to decreased signaling in
macrophages demonstrated by reduction in level and alteration in kinetics of
phosphorylation of AKT and ERK1/2 kinases. Signaling pathway inhibitors revealed that
PI3K, but not MEK, activation was critical for phagocytosis of P. aeruginosa. Despite
altered intracellular signaling in murine macrophages, both mucoid and non-mucoid P.
aeruginosa induced similar levels of IL-8 and MIP-2 from human and murine
macrophages, respectively. By understanding the pathways involved in mediating
efficient phagocytosis of clinical isolates, it may be possible to develop a treatment to
promote clearance by the resident alveolar macrophages. These experiments may
serve as a model to evaluate the effectiveness of such treatments. This approach also
provides valuable insight into previously unknown mechanisms of phagocytosis of P.
aeruginosa.

Chapter 1
Introduction

Pseudomonas aeruginosa
Pseudomonas aeruginosa is a gram-negative, biofilm forming, aerobic rod. P.
aeruginosa is commonly found throughout the environment in soil, surface water,
sewage, plants, and foods (70). While it is a common human intestinal bacterium, P.
aeruginosa is an opportunistic pathogen, which is responsible for a variety of infections
(70). These infections include keratitis, skin infections, urinary tract infections, infections
of the upper and lower respiratory tract, and of the bloodstream (45).
Immunocompromised patients as well as those on mechanical ventilation are at risk of
serious infections by P. aeruginosa (70). Immunocompromised patients include those
with cancer or HIV infection, transplant recipients, and burn patients. Nosocomial
infection by P. aeruginosa presents an important risk for these patients as it increases
the mortality rate by 40% (70). Recent studies have found that while the chance of P.
aeruginosa infection in U.S. hospitals is 4%, it is responsible for 10% of all hospitalacquired infections (HAI) (70). Acute infection of the respiratory tract by P. aeruginosa
often leads to septic shock, multiple organ dysfunction, and has a mortality rate of up to
48% (70). Chronic infection of the airway is very different from acute infections. Chronic
infection of the airway of cystic fibrosis (CF) patients causes significant inflammation
and tissue damage, which is a major cause of morbidity and mortality (70). P.
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aeruginosa infection is very common among patients with cystic fibrosis and is currently
found in 58% of all patients. P. aeruginosa strains isolated from patients with CF are
phenotypically different from those isolated from the environment and these adaptations
promote survival by allowing P. aeruginosa to evade the host immune system. CF
strains often lack flagellin and pilin expression. These CF adapted strains also produce
‘rough’ lipopolysaccharide (LPS), which does not have the long O-side chains
characteristic of ‘smooth’ LPS (70). This change in LPS structure could alter the innate
immune response by affecting binding to phagocytes and inflammatory signaling.
P. aeruginosa virulence factors include antibiotic resistance, biofilm formation,
alginate production, and secreted effectors. Clinical isolates have been found to have
pathogenicity islands which directly contribute to virulence. Secreted effectors such as
elastase, alkaline proteases, hemolysins, cytotoxins, and siderophores promote tissue
invasion. These effectors also protect against the innate and adaptive immune system
by cleaving important receptors, signaling molecules and by inactivating complement
and antibodies (16, 70). P. aeruginosa also produces pyocyanin, which has a
proinflammatory effect in the lungs of CF patients. Pyocyanin also disrupts antioxidant
functions within the lung which leads to oxidative damage to the lung epithelium (70). P.
aeruginosa also secretes several effector proteins via a type III secretion system
including ExoS, ExoT, ExoU, and ExoY (16). Type III secretion involves a molecular
nanomachine to inject effectors directly into target cells (16). These effectors are known
to disrupt intracellular signaling, which can affect phagocytosis and inflammation (9, 16).
For example, ExoS has been shown function as a GTPase-activating protein (GAP) to
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stimulate GTP hydrolysis by RhoA, which regulates cytoskeletal rearrangement and is
involved in PI3K-mediated signaling pathways (9, 16, 22).

Pseudomonas aeruginosa infection in cystic fibrosis
A large amount of research is directed at P. aeruginosa respiratory infections in
patients with cystic fibrosis. Cystic fibrosis is an important respiratory disease that
affects 70,000 people worldwide with 1000 people being diagnosed every year (12). CF
is an autosomal recessive disease caused by a mutation in the cystic fibrosis
transmembrane conductance regulator (CFTR) gene, which produces a cyclic AMPregulated chloride ion channel (18). Over 1,500 possible mutations in the CFTR gene
have been identified, typically leading to the production of a non-functional, and
subsequently degraded, protein (18, 36, 72). The loss of the channel results in defective
chloride ion transport, which has many systematic effects including the production of
highly adhesive mucus (67). This altered mucus production inhibits bacterial clearance
and promotes respiratory infections. A recent study found that 97% of children with CF
were colonized with P. aeruginosa by the age of 3 years and that among all patients
over 58% were infected with P. aeruginosa (70). P. aeruginosa infection in CF is
associated with increased morbidity and mortality (29). Due to the widespread presence
of P. aeruginosa in the environment and the high incidence of hospital acquired
infections, it is important to understand the survival mechanisms responsible for its
persistence within the CF lung (31, 70).
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Alginate regulation and synthesis
P. aeruginosa produces three extracellular polysaccharides called Psl, Pel, and
Alginate. Psl is produced by a fifteen-gene operon and is important for attachment as
well as the maintenance of biofilm structure (69). Psl was found to be required for
adherence to mucin-coated surfaces and airway epithelial cells. Pel is a glucose-rich
matrix polysaccharide produced by a seven-gene operon (69). Pel is important for
pellicle formation and biofilm structure, similar to Psl. However, Pel is biochemically and
genetically distinct from Psl. During colonization of the CF airway, P. aeruginosa
converts from non-mucoid to a mucoid phenotype, characterized by the production of a
capsular exopolysaccharide alginate (13, 46). High levels of alginate have been
measured in the sputum of patients with CF who are chronically infected with P.
aeruginosa (18). Alginate is composed of D-manuronate and L-guluronate, of which the
D-manuronate is O-acetylated. The P. aeruginosa alginate operon is composed of 12
genes controlled by a single promoter, which is ultimately regulated by σ22 (AlgT/U)
(34). σ22 activation leads to the production of AlgR, AmrZ and AlgB, which bind to the
alginate promoter allowing for transcription. σ22 is negatively regulated by the
membrane bound anti-sigma factor, MucA. The conversion from non-mucoid to mucoid
phenotype may be caused by many factors including cell wall stress and oxygen
radicals (11, 13, 53, 87).
Alginate synthesis begins in the cytoplasm and modifications continue while it is
transported through the inner and outer membranes (34, 35). Alginate production
begins with fructose-6-phosphate, a common sugar generated during glycolysis.
Fructose-6-phosphate is rearranged by the phosphomannose isomerase activity of AlgA
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producing mannose-6-phosphate. Phosphomannose mutase, produced by algC, then
moves the phosphate group on mannos-6-phosphate to form mannose-1-phosphate.
The GDP-mannose phosphorylase activity of AlgA uses mannose-1-phosphate, along
with the cofactor GTP, to form GDP-mannose. GDP-mannose dehydrogenase,
produced by algD, then oxidizes the C6 hydroxyl group of GDP-mannose to a carboxylic
acid to form GDP-mannuronic acid. GDP-mannuronic acid is then transported across
the inner membrane by the polymerase, produced by alg8. During this processes GDPmannuronic acid is polymerized by Alg8 with the help of Alg44 to form
polymannuronate. Polymannuronate is then epimerised at the C5 carbons by Dmannuronate C5-epimerase, produced by algG, to form a polymer of D-mannuronate
and L-guluronate subunits. D-mannuronate subunits are O-acetylated by a complex
formed by AlgI, AlgJ, and AlgF. The O-acetyltransferase, produced by algI, transfers an
acetyl group from acetyl-CoA across the inner membrane to AlgJ and AlgF, to be added
to D-mannuronate. The acetylated D-mannuronate-L-guluronate polymer is transported
across the periplasm with the help of several scaffold proteins produced by algX, algL,
and algK. AlgE, recruited by AlgK, forms a porin in the outer membrane to export the
alginate that has been transported across the periplasm (34, 35, 39, 60, 66).
Mucoid conversion of P. aeruginosa in the CF airway is a slow process;
therefore, alginate production is not likely to be responsible for the initial immunological
failure leading to infection and colonization of the CF lung by P. aeruginosa. However,
alginate production by mucoid P. aeruginosa may contribute to maintenance of the
chronic infection by inhibiting its clearance by alveolar macrophages. Alginate
production has been shown to enhance survival through various means including
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promoting biofilm formation and evading complement killing (6, 8, 43). σ22 has also been
shown to promote expression of AmrZ, which inhibits the master regulator of flagellum
expression, FleQ (78, 79). 39% of P. aeruginosa CF isolates were found to be nonmotile and several studies have shown that the non-motile phenotype may enhance the
survival of P. aeruginosa in the CF lung by evading phagocytosis (1, 47, 50, 51). It has
been reported that mucoid P. aeruginosa is resistant to opsonic and non-opsonic
phagocytosis, and that alginate production by P. aeruginosa confers protection against
IFN-γ mediated opsonic killing of a P. aeruginosa biofilm (8, 43, 46, 63, 68). There are
low levels of opsonins found in the lung environment, and the effects of alginate
production on phagocytosis by macrophages in a serum-free environment have not
previously been extensively studied (29).

Phagocytosis
Phagocytosis is an actin-dependent process that involves the use of multiple cell
surface receptors to bind pathogens and cell debris (16, 84). Macrophages also extend
actin-dependent projections to search the surrounding environment for pathogens (16).
This internalization requires a complicated series of membrane remodeling, cytoskeletal
rearrangement, and intracellular signaling events. The result of these events is the
formation of a phagosome, the engulfment of the pathogen, and the release of
inflammatory cytokines. Multiple receptors come together and form multimers within
lipid rafts to enhance binding capacity. This is necessary because bacterial movement,
due to Brownian motion and flagellar motility, will cause the bacteria to detach if there
are only low affinity interactions (16).
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Phagosome formation begins with an increase in phosphatidylinositol-4,5bisphosphate (PI(4,5)P2) concentration in the cell membrane. Phosphatidylinositide 3kinase (PI3K) stimulates phospholipase C (PLC)-γ which modifies PI(4,5)P2 into
phosphatidylinositol-3,4,5-trisphosphate (PI(3,4,5)P3) until the phagosome has sealed.
After sealing, PI(3,4,5)P3 is once again modified to become phosphatidylinositol 3phosphate (PI(3)P) which is the primary lipid in early phagosomes (16). These early
phagosomes bind to early endosomes and eventually late endosomes and lysosomes
to form late phagosomes and late phagolysosomes (16). This results in the acidification
of the phagosome and destruction of the pathogen.
Phagocytosis involves two broad categories of receptors, opsonic receptors and
pattern-recognition receptors. Opsonic phagocytosis requires receptors that bind an
intermediary molecule which binds to the target bacteria. Opsonic receptors include Fc
receptors such as FcγRI, FcγRII, and FcγRIII and complement receptors such as CR1,
CR3 (CD11b/CD18, MAC-1), and CR4 (CD11c/CD18) (16). For opsonic phagocytosis
Fcγ receptors bind various IgG antibodies, while complement receptors bind mannanbinding lectin (MBL) and various complement fragments. However, further research has
revealed that these opsonic receptors are also capable of binding bacterial ligands
directly and that these interactions are critical for host defense. For example,
complement receptor 3 is able to bind numerous ligands including LPS, LPG
(lipophosphoglycan), acylpolygalactoside (APG), β-glucans, intercellular adhesion
molecules (ICAM)-1, ICAM-2, ICAM-3, β-amyloid, high mobility group box 1 (HMGB1),
and oligodeoxynucleotide (7, 89). As a result, CR3 has been found to be important for
cellular binding and internalization by murine macrophages (27). Pattern-recognition
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receptors recognize a broad range of pathogen-associated molecular patterns
(PAMPs). These receptors include Toll-like receptors (TLR) and scavenger receptors
(SR) which are also critical to host defense (16, 84). Both SR-A and TLR-4 (with CD14)
are able to bind LPS (16). However, it is possible that alterations to LPS structure may
result in altered signaling through these receptors. Several macrophage receptors have
been implicated in the phagocytosis of P. aeruginosa. These receptors include TLR2,
TLR4, TLR5, mannose receptor (MR), CR3, CR4, SR-A, MARCO and Fc receptors (4,
16, 29, 38, 70, 74). However, the contribution of each receptor varies depending on the
P. aeruginosa strain that is used. Although, antibodies to alginate are generated by CF
patients with chronic P. aeruginosa infections, these antibodies have been shown to be
unable to mediate opsonic killing in vitro (69).
Phagocytosis plays an important role in clearing cell debris, including apoptotic
cells (16). Phosphatidylserine (PS) is a lipid that is restricted to the inner leaflet of the
plasma membrane. Apoptosis exposes this lipid as a marker for clearance. MFG-E8
(lactadherin) binds PS which is then bound by several phagocytic receptors including
αVβ3 integrin, CD36, and CD68 (16). While phagocytosis of pathogens induces the
production of inflammatory cytokines, phagocytosis of apoptotic cells induces antiinflammatory cytokines to prevent tissue damage (16).
Activation of the above receptors results in the activation of a wide range of
interconnected signaling pathways that lead to the formation of the phagocytic cup and
the release of inflammatory cytokines and chemokines. Efficient phagocytosis of P.
aeruginosa is dependent on PI3K signaling, leading to the phosphorylation and
activation of certain signaling molecules, such as AKT and NF-kB (37). NF-κB is a
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transcription factor that is activated when the inhibitor of NF-κB alpha (IκBα) is
phosphorylated, leading to its degradation (42). Once free from IκBα, NF-κB
translocates to the nucleus and promotes the expression of inflammatory cytokines
including IL-8, TNF-α, and IL-6. AKT inhibition has resulted in inhibited phagocytosis of
PAO1 by murine macrophages (37). ERK activation may also contribute to
phagocytosis of P. aeruginosa as it has been shown that ERK activation leads to
phosphorylation of myosin light chain kinase (MLCK) in polymorphonuclear leukocyte
(PMNL) and epithelial cells (52, 58). Phosphorylation of MLCK leads to actin
rearrangement, which is necessary for the formation of the phagocytic cup. Actin
rearrangement during phagocytosis is also dependent on the Rho GTPase Rac (16).
Prior to these signaling events, ceramide accumulation and lipid raft formation within the
phagocytic cup may also be critical to the phagocytosis of P. aeruginosa (23).

The macrophage response to Pseudomonas aeruginosa in the cystic fibrosis
lung
Significant numbers of macrophages are found in the CF airway (2). However,
macrophages isolated from P. aeruginosa infected CF patients exhibit a M2 phenotype,
which can mediate chronic inflammation (28). The mechanism by which alginate
protects P. aeruginosa from opsonic and non-opsonic phagocytosis is unclear. When
the murine macrophage cell line RAW264.7 is exposed to alginate, production of
inflammatory cytokines, such as TNF-α and Interleukin 6 (IL-6), are up-regulated (88). CF
is also associated with increased Interleukin 8 (IL-8) production within the lung (77).
This suggests that alginate is able to affect macrophage activation, which could affect

9

inflammatory cytokine production in the CF airway. The CFTR mutation may further
complicate inflammatory signaling within the CF lung. A mutation in the CFTR gene has
been shown to lead to an up-regulation of inflammatory cytokine production by airway
epithelial cells (49). Inflammatory cytokines released by epithelial cells, and to a lesser
extent macrophages, exacerbate the disease by recruiting large numbers of neutrophils
to the airway and causing tissue damage (11). This is likely due to constitutively active
NF-kB (49). The recruited neutrophils are unable to clear the infection and further
contribute to the disease by providing a DNA and F-actin rich environment for P.
aeruginosa growth (6). P. aeruginosa utilizes polymers of DNA and F-actin, provided by
the neutrophils, to form biofilms in the CF airway (86). These neutrophils are also a
source of oxygen radicals, which may induce mucoid conversion in P. aeruginosa (53).

Scope of this project
Understanding how alginate production by P. aeruginosa leads to enhanced
survival in the context of the CF lung is important for the treatment of CF lung infections.
By understanding which receptors and signaling pathways are critical to the
phagocytosis of mucoid P. aeruginosa, it may be possible to stimulate the alveolar
macrophages to enhance clearance of an established infection. Prior to this
dissertation, the mechanism by which alginate inhibits macrophage phagocytosis of P.
aeruginosa was not well characterized. This was accomplished by using a combination
of microbiological and immunological assays to determine the role of alginate in
inhibiting phagocytosis.
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To address this problem, I first determined the effect of alginate on opsonic and
non-opsonic phagocytosis by human and murine macrophages. I found that alginate
was able to inhibit phagocytosis in both types of macrophages, under opsonic and nonopsonic conditions. I followed this up by determining how and when alginate is able to
inhibit phagocytosis, as well as determining how other factors influence phagocytosis of
P. aeruginosa. This revealed that alginate production has a local inhibitory effect by
blocking binding to the macrophage. I continued by investigating the inhibitory effect of
alginate on macrophage receptor binding, intracellular signaling, and extracellular
signaling. This revealed important phagocytosis receptors, the blocking of which causes
altered activation of critical phagocytosis signaling pathways and reduced phagocytosis.
This research could provide important information leading to a better understanding of
the chronic lung infection in CF as well as providing information on the mechanisms
involved in the phagocytosis of P. aeruginosa by human and murine macrophages.
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Chapter 2
Materials and Methods

Bacterial culture media and growth conditions
All Pseudomonas aeruginosa and Escherichia coli strains were grown on LuriaBertani (LB) agar plates. Following growth on solid media, all strains were grown in LB
liquid media at 37°C with shaking. Antibiotics were used when necessary for plasmid
maintenance at the following concentrations: ampicillin, 100 µg/ml; carbenicillin, 150
µg/ml; kanamycin, 30 µg/ml.

Bacterial strains and plasmids
The bacterial strains used in this study are described in Table 1. Plasmids used
in this study are described in Table 2. FRD1 is a cystic fibrosis clinical isolate in which
alginate production is constitutively active due to a mucA mutation, which prevents
MucA from sequestering σ22. FRD1131 is an isogenic mutant of FRD1 that contains an
algD::Tn501-33 mutation. algD is the first gene in the alginate operon and the
transposon is polar on all downstream genes, so FRD1131 is unable to produce
alginate, regardless of σ22 regulation. PAO1 is a clinical wound isolate that does not
produce alginate. PDO300 is a PAO1 mucA mutant in which alginate production is
constitutively active.
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GFP-expressing strains were constructed by transfering pMF230 into the
recipient strain by conjugation. The mCherry plasmid was constructed by PCR
amplifying the gene from pMP7605 with the following primers: 5’gatcaagcttttacttgtacagctcgtccat-3’ and
5’-gatctctagaatggtgagcaagggcgagg-3’ (44). DNA was ligated to the pMF54 plasmid, a
broad-host range expression vector, and transformed into competent DH5α cells. The
completed plasmid was then transferred into the recipient strains by conjugation.
For purposes of judging multiplicity of infection (MOI) for all experiments, colony
counts were used. Overnight cultures of bacterial strains were diluted 1:10 and grown
for 2 hours until mid-log phase growth (0.8 at OD600). 1 ml of each strain was
centrifuged at 14,000 RPM for 3 minutes. Supernatants were removed and the pellet
was resuspended in 1 ml of RPMI. The number of resuspended bacteria was
determined by serially diluting 100 µl 1:10, and spreading 100 µl of the dilutions on LB
agar plates. After overnight incubation at 37°C, colonies were counted to determine
colony forming units (CFU). This CFU count was used to determine the MOI for
subsequent experiments.

Strain construction
Sequence-defined transposon insertions in PAO1 from a mutant library were moved by
transduction to PAO and FRD strains (30). Phage F116L plate lysates were made on a
library mutant. The filter sterilized lysate was incubated for 4 hours with the recipient
strain and then plated onto LB-agar with tetracycline (100 µg/ml) to select for
inheritance of the transposon by homologous recombination.
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Macrophage culture
THP-1 and MH-S macrophages were purchased from ATCC (TIB-202 and CRL2019, respectively) and grown in complete RPMI containing 10% FBS (Gibco), 1%
penicillin and streptomycin, and 1% L-glutamine. Cells were counted by hemocytometer
prior to plating for each experiment. THP-1 macrophages were differentiated with 12-Otetradecanoylphorbol-13-acetate (TPA) (Sigma, final concentration 3.2 x 10-7 M) for 2
days prior to infection experiments (82).

Flow cytometry based phagocytosis assay
2x105 THP-1 or MH-S macrophages were grown in 12-well plates prior to infection.
Overnight cultures of GFP-expressing bacterial strains were diluted 1:10 and grown for
2 hours until mid-log phase growth (0.8 at OD600). 1 ml of each strain was centrifuged
at 14,000 RPM for 3 minutes. Supernatants were removed and the pellet was
resuspended in 1 ml of RPMI. 10 µl of the resuspended bacterial strains were added to
the macrophages, resulting in an MOI of 50, and incubated at 37°C in 5% CO2 for 30
minutes. Macrophages were then washed and harvested with 0.02% EDTA in PBS and
analyzed by flow cytometry to determine the amount of internalized GFP-expressing
bacteria. Macrophage gating was determined first by forward scatter versus side scatter
to eliminate dead cells and debris. Secondary gating was determined by GFP
expression versus red autofluorescence to count the number of macrophages
containing GFP-expressing bacteria (41, 64, 75, 81).
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Table 1. Description of bacterial strains
Name
P. aeruginosa
FRD1
FRD1131
FRD1131C’
FRD1 GFP
FRD1131 GFP
FRD1 FlgFRD1131 FlgFRD1 mC
FRD1131 mC
FRD1810
PAO1
PDO300
PAO1 Flg-

Genotype and/or Phenotype
mucA22 Alg+ LPS-OFRD1algD::Tn501-33 AlgFRD1131(pAlg2) Cbr Alg+
FRD1(pMF230) Cbr GFP+
FRD1131(pMF230) Cbr GFP+
FRD1 flgB::Tn mariner Tcr FlgFRD1131 flgB::Tn mariner Tcr FlgFRD1(pWR01) Cbr mCherry (mC+)
FRD1311(pWR01) Cbr mCherry (mC+)
FRD1, LPS-O4+
WT AlgPAO1 mucA22 Alg+
PAO1 flgB::Tn Tcr Flg-

(61)
(10)
This study
This study
This study
Ohman lab strain
Ohman lab strain
This study
This study
Ohman lab strain
(32)
(53)
Seattle library

E. coli
DH5α GFP
DH5α
DH5α
DH5α
HfrH
HfrH GFP

DH5α(pMF230) Apr GFP+
DH5α(pRK2013) Tra+ Kmr
DH5α(pAlg2) Cbr algD operon
DH5α(pWR01) Apr mCherry (mC+)
WT
HfrH(pMF230) Apr GFP+

Ohman lab strain
Ohman lab strain
Ohman lab strain
This study
(5)
This study
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Source

Table 2. Description of bacterial plasmids
Name

Genotype

Source

pMF230

pMF36 oriT SF Ptrc-GFP Apr

(59)

pRK2013

ColE1-Tra(RK2)+ Kmr

(15)

pAlg2

cos oriT Apr Kmr algD operon

(10)

pMF54

oriV, Ptrc, lacIq, oriT(RK2) bla

(60)

pMP7605

pBBR1MCS-5 mCherry (mC+) Gmr

(44)

pWR01

pMF54 Ptrc-mCherry (mC+) Cbr

This study
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Gentamicin protection assay
2x105 THP-1 or MH-S macrophages were grown in 12-well plates prior to
infection. Overnight cultures of bacterial strains were diluted 1:10 and grown for 2 hours
until mid-log phase growth (0.8 OD600). 1 ml of each culture (1 x 109 cells/ml) was
centrifuged at 14,000 RPM for 3 minutes. Supernatants were removed and the pellet
was resuspended in 1 ml of RPMI. Macrophages were infected with 10 µl of the
resuspended bacterial strains (1 x 107 cells), resulting in a MOI of 50, and incubated at
37°C in 5% CO2 for 1 hour. MH-S cells were washed with cold PBS, treated with
gentamicin (2 mg/ml) for 30 minutes to kill extracellular bacteria, washed twice with cold
PBS, and subsequently lysed with 0.25% SDS to release intracellular bacteria. Cell
lysates were serially diluted 1:10 and 100 µl of the dilutions were spread on LB agar
plates. Plates were incubated at 37°C overnight and colonies were counted to
determine CFU. For some experiments, blocking antibodies were added 15 minutes
prior to infection and signaling inhibitors were added 30 minutes prior to infection, and
both remained present during phagocytosis. Controls including wells containing only
bacteria were treated with gentamicin (2 mg/ml) for 30 minutes or 0.25% SDS which
resulted in 0% or 100% CFU, respectively, compared to untreated wells (14, 17, 55).

Intracellular survival assay
2x105 THP-1 macrophages were grown in 12-well plates prior to infection.
Overnight cultures of bacterial strains were diluted 1:10 and grown for 2 hours until midlog phase growth (0.8 OD600). 1 ml of each strain was centrifuged at 14,000 RPM for 3
minutes. Supernatants were removed and the pellet was resuspended in 1 ml of RPMI.
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Macrophages were infected with 10 µl of the resuspended bacterial strains, resulting in
a MOI of 50, and incubated at 37°C in 5% CO2 for 2 hours. Macrophages were washed
with cold PBS and treated with gentamicin (2 mg/ml) for 30 minutes. Following
gentamicin treatment (Time 0) macrophages were incubated at 37°C in 5% CO2 for 2
hours. At varying time points throughout the 2 hour incubation, macrophages were
washed twice with cold PBS and lysed with 0.25% SDS to release intracellular bacteria.
Cell lysates were serially diluted 1:10 and 100 µl of the dilutions was spread on LB agar
plates. Plates were incubated at 37°C overnight and colony counts were performed
(55).

Microscopy
THP-1 or MH-S macrophages were grown in chamber slides or glass bottom
dishes prior to infection. Overnight cultures of bacterial strains were diluted 1:10 and
grown for 2 hours until mid-log phase growth (0.8 OD600). 1 ml of each strain was
centrifuged at 14,000 RPM for 3 minutes. Supernatants were removed and the pellet
was resuspended in 1 ml of RPMI. For fluorescent microscopy, bacterial strains
expressing GFP were added at a MOI of 500 for 2 hours and visualized with a Zeiss
Axiovert 200 using a green filter. For confocal microscopy, MH-S macrophages were
labeled using Alexa488-Cholera Toxin B (Molecular Probes) to label ganglioside GM1 in
the membranes for 15 minutes prior to the addition of mCherry-expressing bacteria.
Macrophages were washed and fixed with 4% formaldehyde for 15 minutes.
Formaldehyde was removed and macrophages were washed once with PBS.
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Macrophages and associated bacteria were visualized using a Zeiss LSM 710 confocal
microscope at 63x magnification (33, 37).

Swimming motility assay
Overnight cultures of bacterial strains were diluted 1:10 and grown for 2 hours
until mid-log phase growth (0.8 OD600). 0.5% LB agar plates were point inoculated with
1 µl of the mid-log phase bacterial culture and incubated at 37°C overnight. 24 hours
later, the diameter of the resulting growth was measured (21, 48).

Alginate isolation and purification
Strain FRD1 was grown overnight in 10 ml of LB liquid media at 37°C with
shaking, and 1 ml was used to inoculate 100 ml of fresh LB, which was incubated
overnight at 37°C with shaking. The culture was then centrifuged at 10,000 rpm for 60
minutes. Supernatants were moved to a sterile beaker where 2 volumes of cold ethanol
were added and mixed. The precipitate was removed with a sterile glass plate spreader
and placed into a petri dish and dried at 37°C. The precipitate was dissolved in 100 ml
of 1 M NaCl overnight at 5°C with agitation. 100 ml of cold isopropanol was added and
the solution was centrifuged at 10,000 RPM and 5°C for 60 minutes to collect the
precipitate. The resulting precipitate was removed with a sterile glass plate spreader
and dissolved in 20 ml saline, overnight at 37°C with shaking. Once dissolved, trypsin
(0.5 mg/ml) was added to eliminate contaminating proteins, and incubation continued
for 2 hours at 37°C with shaking. 1 g of NaCl was added followed by 1 volume of cold
isopropanol. The solution was centrifuged at 10,000 RPM and 5°C for 60 minutes. The
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resulting precipitate was dissolved in 20 ml saline. The solution was dialyzed against
distilled water (19).

Alginate concentration
A borate stock was prepared by dissolving 2.474 g of H3BO3 in 4.5 ml of 4 M
KOH and diluting to 10 ml with distilled water. A sulfuric acid-borate reagent was
prepared by diluting 500 µl of borate stock up to 20 ml with H2SO4. A carbazole stock
was prepared by adding 10 mg of carbazole to 10 ml ethanol. An alginate stock solution
was prepared by adding 20 mg of sodium alginate (Sigma) to 10 ml saline.
1 ml of the sulfuric acid-borate reagent was added to a glass tube on ice. 100 µl
of an alginate sample solution or control was layered on top of the sulfuric acid-borate
reagent and the tube was vortexed and placed on ice for 3 minutes. 33 µl of carbazole
reagent was added and the tube was vortexed and placed on ice for 3 minutes. The
tubes were incubated in a 55°C water bath for 30 minutes. Following incubation,
samples were removed and analyzed by spectrophotometry. Absorbance was
measured at 530 nm. A standard curve was generated using the alginate stock solution
and was assayed in duplicate. Standard curve data was graphed and alginate
concentration was calculated by determining the equation of the resulting trend line
(40).

Western blot analysis
2x106 MH-S macrophages were grown in 6-well plates prior to infection. Overnight
cultures of bacterial strains were diluted 1:10 and grown for 2 hours until mid-log phase
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growth (0.8 OD600). 1 ml of each strain was centrifuged at 14,000 RPM for 3 minutes.
Supernatants were removed and the pellet was resuspended in 1 ml of RPMI.
Macrophages were starved in serum-free RPMI for 6 hours and subsequently infected
with 100 µl of the resuspended bacterial strains, resulting in a MOI of 50, and incubated
at 37°C in 5% CO2 for various time points. After infection, macrophages were washed
twice with cold PBS and lysed with 70 µl RIPA (Cell Signal) containing 1 mM PMSF.
Samples were centrifuged at 14,000 x g for 10 minutes and supernatants were frozen at
-80°C for storage prior to analysis. Protein concentration was determined using a
Bradford protein assay, and 20 µg of protein was separated on a 12% polyacrylamide
gel in Tris-glycine electro-blotting buffer (National Diagnostics ec-870) for 90 minutes at
150 V. Proteins were transferred to PVDF with a semi-dry transfer cell (Bio-Rad) in Trisglycine-SDS buffer (National diagnostics ec-880) at 25 V for 30 minutes. The blot was
blocked with 2% BSA in TBS/Tween (0.05%, Amresco K873) for 1 hour. Primary
antibodies to various macrophage proteins (Cell Signal, 4060, 4691, 4370, 4695) were
used at 1:1000 in TBS/Tween with 2% BSA overnight, at 4°C with shaking. The blot was
washed 3 times, for 10 minutes each, with TBS/Tween and secondary antibodies were
added. α-Rabbit IgG-peroxidase secondary antibody (Sigma A9169) was used at
1:5000 in TBS/Tween with 2% BSA for 45 minutes at room temperature with shaking.
The blot was washed 4 times, for 10 minutes each, with TBS/Tween. West Pico
chemiluminescence substrate (Thermo Sci 34080) was added for 5 minutes prior to film
exposure. To strip the blot to allow for additional probes, stripping buffer (Thermo Sci
21059) was added for 15 minutes at room temperature with shaking. The blot was
washed with TBS/Tween and blocked with 2% BSA for 1 hour.
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Acid sphingomyelinase activity
2x106 MH-S macrophages were grown in 6-well plates prior to infection.
Overnight cultures of bacterial strains were diluted 1:10 and grown for 2 hours until midlog phase growth (0.8 OD600). 1 ml of each strain was centrifuged at 14,000 RPM for 3
minutes. Supernatants were removed and the pellet was resuspended in 1 ml of RPMI.
Macrophages were serum starved for 6 hours prior to infection. 100 µl of the
resuspended bacterial strains were added, resulting in a MOI of 50, and incubated at
37°C in 5% CO2 for 15 minutes. The macrophages were washed twice with cold PBS
and scraped using water with 1mM PMSF. Cells were harvested and lysed by three
freeze-thaw cycles in liquid nitrogen. Samples were spun at 14,000 x g for 10 minutes to
remove cell membranes and debris, and supernatants were frozen at -80°C for storage
prior to analysis. Protein concentration was determined using a Bradford protein assay
and ASMase activity in 2 µg of protein was measured using an ASMase activity assay
kit (Echelon K-3200).

IL-8 and MIP-2 ELISA
2x105 THP-1 or MH-S macrophages were grown in 12-well plates prior to
infection. Overnight cultures of bacterial strains were diluted 1:10 and grown for 2 hours
until mid-log phase growth (0.8 OD600). 1 ml of each strain was centrifuged at 14,000
RPM for 3 minutes. Supernatants were removed and the pellet was resuspended in 1
ml of RPMI. MH-S and THP-1 cells were infected with 10 µl of the resuspended
bacterial strains, resulting in a MOI of 50, and incubated at 37°C in 5% CO2 for 8 hours.
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Supernatants were collected and centrifuged to remove any remaining bacteria. IL-8 or
MIP-2 levels were determined by ELISA Quantikine kit (R&D Systems d8000c, mm200).
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Chapter 3
Alginate Production by Pseudomonas aeruginosa Inhibits Opsonic
and non-Opsonic Phagocytosis by Human and Murine Macrophages

Mucoid Pseudomonas aeruginosa inhibits phagocytosis by human macrophages
Previous studies indicated that mucoid Pseudomonas aeruginosa are protected
from non-opsonic phagocytosis (8, 43, 68). However, these findings came from visual
observations and were not compared to proper controls. The effect of alginate
production on non-opsonic phagocytosis of planktonic P. aeruginosa by macrophages
has not been quantitatively studied and may contribute to the survival of P. aeruginosa
within the CF lung. To understand the effect of alginate on phagocytosis of P.
aeruginosa, I first wanted to establish a time course for phagocytosis using the human
monocytic cell line, THP-1. P. aeruginosa strain FRD1, an alginate producing (Alg+) CF
isolate, and its isogenic algD::Tn501-33 (Alg-) mutant were compared. GFP-expressing
FRD1 and FRD1131 were incubated with THP-1 macrophages and were analyzed by
flow cytometry at various time points up to 4 hours (Figure 1). At the earliest time point,
phagocytosis of FRD1131 exceeded that of FRD1 by 25%. This trend continued out to 4
hours despite increased phagocytosis of both strains.

24

25

Figure 1. Time course of phagocytosis of FRD1 and FRD1131 by THP-1
macrophages. THP-1 macrophages were infected with GFP-expressing FRD1 (Alg+) or
FRD1131 (Alg-) at a MOI of 500 for various time points up to 4 hours. Percent
phagocytosis indicates the percent of macrophages that are associated with GFPexpressing P. aeruginosa as detected by flow cytometry. Data are shown as mean and
standard deviation of two samples.

26

GFP-expression was detectable by flow cytometry, and I wanted to determine if
there was enough GFP-expression to observe phagocytosis by fluorescent microscopy.
After establishing that phagocytosis could be observed as early as 30 minutes post
infection, I visualized the difference at that time point. GFP-expressing FRD1 and
FRD1131 were added to THP-1 macrophages and visualized using fluorescent
microscopy (Figure 2). An overlay of the fluorescent P. aeruginosa on a light image of
the macrophages revealed many more Alg- FRD1131 within, and associated with, the
macrophages compared to the Alg+ FRD1.

Alginate+ Pseudomonas aeruginosa reduce the proportion of human
macrophages that phagocytize and the total amount of bacteria phagocytized
Using the time point at which phagocytosis was maximal, flow cytometry was
repeated to determine if alginate production significantly affects phagocytosis. After a 30
minute incubation, alginate production by FRD1 significantly reduced the amount of
phagocytosis by THP-1 macrophages (Figure 3). This indicates that alginate production
is protective under non-opsonic conditions.
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Figure 2. Visualization of THP-1 macrophages following phagocytosis of GFPexpressing FRD1 and FRD1131. Images show GFP-expressing P. aeruginosa
overlayed on a light image of THP-1 macrophages. THP-1 macrophages were infected
with GFP-expressing FRD1 (Alg+) or FRD1131 (Alg-) for 30 minutes and visualized by
fluorescent microscopy. Reduced phagocytosis and association with macrophages are
observed with the FRD1 compared to the FRD1131 strain.
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Figure 3. Percentage of THP-1 macrophages that have phagocytized FRD1 and
FRD1131 at 30 minutes. THP-1 macrophages were infected with GFP-expressing
FRD1 (Alg+) or FRD1131 (Alg-) for 30 minutes. Percent phagocytosis indicates the
percent of macrophages that are associated with GFP-expressing P. aeruginosa as
detected by flow cytometry. Phagocytosis of FRD1 was significantly inhibited compared
to FRD1131. Data are shown as mean and standard deviation of three samples.
Statistical significance is determined by Students t-Test (*; P < 0.05, **; P < 0.01, ***; P
< 0.001).
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It is possible for some bacteria to remain on the outside of the macrophages
despite washing prior to flow cytometric analysis. Therefore, too ensure that the
observed difference in phagocytosis was indeed due to internalized bacteria, an
alternative phagocytosis assay was used. In this assay, FRD1 or FRD1131 were
incubated with THP-1 macrophages for 1 hour and macrophages were subsequently
washed and treated with gentamicin to kill extracellular bacteria. After lysing the
macrophages and plating the lysate, colony counts were performed. It is important to
note that this assay measures the number of bacteria phagocytosed, whereas the flow
cytometric assay measures the number of macrophages that have phagocytized
bacteria. As in the previous assay, alginate production by FRD1 significantly inhibited
phagocytosis by THP-1 macrophages (Figure 4). To ensure that the inhibition of
phagocytosis was due to the production of alginate alone, I complemented algD in
FRD1131 (FRD1131C’) to restore alginate production. Alginate production by
FRD1131C’, as with FRD1, was able to significantly inhibit non-opsonic phagocytosis,
suggesting that alginate alone was responsible for the inhibition of phagocytosis that
was observed. Together these data indicated that alginate production by P. aeruginosa
significantly reduced the proportion of macrophages that phagocytosed P. aeruginosa,
as well as the total number of bacteria phagocytized by the macrophages.
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Figure 4. Number of bacteria phagocytized by THP-1 macrophages after 1 hour.
THP-1 macrophages were infected with FRD1 (Alg+), FRD1131 (Alg-), FRD1131C’
(Alg+), or HfrH (positive control) for 1 hour. CFU indicates the number of colony-forming
units recovered from macrophages. Phagocytosis of FRD1 and FRD1131C’ was
significantly inhibited compared to FRD1131. Data are shown as mean and standard
deviation of a representative triplicate experiment. Statistical significance is determined
by Students t-Test (*; P < 0.05, **; P < 0.01, ***; P < 0.001).
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Intracellular survival of Pseudomonas aeruginosa is unaffected by alginate
production
It is possible that alginate enhances survival of P. aeruginosa by altering
intracellular survival after phagocytosis. To determine the amount of intracellular
survival, a modified phagocytosis assay was used. THP-1 macrophages were cultured
with FRD1 or FRD1131 for 2 hours. Instead of lysing the macrophages immediately
after gentamicin treatment, macrophages were cultured for up to two additional hours
and lysed at 30 minute intervals. This allowed me to determine the number of P.
aeruginosa that have survived within the macrophages over 2 hours (Figure 5). Survival
rates between the two strains remained similar at each time point throughout the 2 hour
period. Thus, alginate production by FRD1 did not appear to enhance intracellular
survival within macrophages.
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Figure 5. Time course of intracellular survival of FRD1 and FRD1131 within THP-1
macrophages. THP-1 macrophages were infected with FRD1 (Alg+) or FRD1131 (Alg-)
for 2 hours and incubated for additional time following gentamicin treatment. Percent
survival indicates the number of colony-forming units recovered from macrophages at
the indicated time point relative to time 0. Survival of FRD1 was similar to that of
FRD1131 at each time point. Data are shown as mean and standard deviation of two
separate experiments.
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Alginate+ Pseudomonas aeruginosa reduce the proportion of murine alveolar
macrophages that phagocytize and the total amount of bacteria phagocytized
In cystic fibrosis, P. aeruginosa will encounter alveolar macrophages within the
lung. Alveolar macrophages differ from peripheral macrophages in several important
ways including different receptor expression, altered activation, and survival (25, 56).
Therefore, it was important to determine if alginate production also affected
phagocytosis by alveolar macrophages. To investigate this, the murine alveolar
macrophage cell line MH-S was used. As with THP-1, I first wanted to establish a time
line for phagocytosis. Again, substantial phagocytosis was observed as early as 30
minutes post infection and continued out to 1 hour (Figure 6). There was also an
observable difference in the phagocytosis of FRD1 (Alg+) compared to FRD1131 (Alg-).
To confirm that alginate production significantly inhibited phagocytosis by MH-S
macrophages, flow cytometry was used. MH-S macrophages were incubated with FRD1
or FRD1131 for 30 minutes. Similarly to THP-1 macrophages, alginate production by P.
aeruginosa significantly inhibited non-opsonic phagocytosis by MH-S (Figure 7).
The gentamicin uptake assay was also repeated using MH-S macrophages to
confirm the inhibition observed in the flow cytometric assay. FRD1, FRD1131, or
FRD1131C’ were added to MH-S macrophages for 1 hour. Colony counts revealed the
significant inhibitory effect of alginate production by FRD1 on phagocytosis (Figure 8).
Additionally, the Alg+ complemented strain, FRD1131C’, was also phagocytized
significantly less than Alg- FRD1131, suggesting that alginate production alone is
responsible for the inhibition of phagocytosis that is observed.
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Figure 6. Time course of phagocytosis of FRD1 and FRD1131 by MH-S
macrophages. MH-S macrophages were infected with GFP-expressing FRD1 (Alg+) or
FRD1131 (Alg-) for various time points up to 1 hour. Percent phagocytosis indicates the
percent of macrophages that are associated with GFP-expressing P. aeruginosa as
detected by flow cytometry. Reduced phagocytosis of FRD1 compared to FRD1131 is
observed as early as 30 minutes.
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Figure 7. Percentage of MH-S macrophages that have phagocytized bacteria at 30
minutes. MH-S macrophages were infected with GFP-expressing FRD1 (Alg+),
FRD1131 (Alg-), or HfrH for 30 minutes. Percent phagocytosis indicates the percent of
macrophages that are associated with GFP-expressing bacteria as detected by flow
cytometry. Phagocytosis of FRD1 was significantly inhibited compared to FRD1131.
Data are shown as mean and standard deviation of three separate experiments.
Statistical significance is determined by Students t-Test (*; P < 0.05, **; P < 0.01, ***; P
< 0.001).
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Figure 8. Number of bacteria phagocytized by MH-S macrophages after 1 hour.
MH-S macrophages were infected with FRD1 (Alg+), FRD1131 (Alg-), FRD1131C’ (Alg+),
or HfrH for 1 hour. CFU indicates the number of colony-forming units recovered from
macrophages. Phagocytosis of FRD1 and FRD1131C’ was significantly inhibited
compared to FRD1131. Data are shown as mean and standard deviation of three
separate experiments. Statistical significance is determined by Students t-Test (*; P <
0.05, **; P < 0.01, ***; P < 0.001).
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Alginate+ Pseudomonas aeruginosa inhibit opsonic phagocytosis by human and
murine macrophages
Previous studies investigated the role of alginate structure in protecting
planktonic P. aeruginosa, as well as P. aeruginosa in a biofilm, from opsonic killing (43,
46, 63). However, because these studies only addressed bacterial survival rather than
phagocytosis directly, I wanted to repeat them with our macrophage cell lines. First it
was necessary to determine the optimal concentration of human serum necessary for
opsonic phagocytosis. MH-S macrophages were incubated with FRD1 and FRD1131 for
30 minutes with increasing concentrations of human serum (Figure 9). At all
concentrations of serum tested, phagocytosis of Alg+ FRD1 appeared much lower than
Alg- FRD1131, suggesting that alginate inhibits opsonic phagocytosis. 0.5% human
serum was chosen for further experiments as this was the lowest concentration that
enhanced phagocytosis.
To determine if alginate significantly inhibited opsonic phagocytosis, previous
assays were repeated using the established concentration of 0.5% human serum. THP1 macrophages were incubated for 1 hour with various bacterial strains in the presence
of human serum. After treatment with gentamicin, colony counts were performed to
determine the amount of phagocytosis (Figure 10). Both Alg+ FRD1 and the Alg+
complementation strain, FRD1131C’, were phagocytized significantly less than AlgFRD1131.
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Figure 9. Time course showing the percentage of MH-S macrophages that have
phagocytized FRD1 or FRD1131 with increasing concentrations of human serum.
MH-S macrophages were infected with GFP-expressing FRD1 (Alg+) or FRD1131 (Alg-)
for 30 minutes in the presence of increasing concentrations of human serum. Percent
phagocytosis indicates the percent of macrophages that are associated with GFPexpressing P. aeruginosa as detected by flow cytometry. An increase in the
phagocytosis of FRD1 compared to FRD1131 is observed beginning at 0.5% human
serum.
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Figure 10. Number of bacteria phagocytized by THP-1 macrophages after 1 hour
in the presence of 0.5% human serum. THP-1 macrophages were infected with
FRD1, FRD1131, FRD1131C’, or HfrH for 1 hour in the presence of 0.5% human serum.
CFU indicates the number of colony-forming units recovered from macrophages.
Opsonic phagocytosis of FRD1 and FRD1131C’ were significantly inhibited compared to
FRD1131. Data are shown as mean and standard deviation of a representative triplicate
experiment. Statistical significance is determined by Students t-Test (*; P < 0.05, **; P <
0.01, ***; P < 0.001).
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Inhibition of opsonic phagocytosis was assessed in MH-S macrophages as well.
MH-S macrophages were cultured with GFP-expressing FRD1, FRD1131, or HfrH in the
presence of 0.5% human serum for 30 minutes and analyzed by flow cytometry (Figure
11). Similarly to THP-1, opsonic phagocytosis of FRD1 was significantly less than that
of FRD1131.

The inhibitory effect of alginate on phagocytosis by murine macrophages is not
limited to the FRD strain
As an additional control for strain specific effects to ensure that alginate is
responsible for the inhibitory effect on phagocytosis, another P. aeruginosa strain was
utilized. PAO1 is a clinical wound isolate routinely used in many labs. PDO300 is a
mutant strain of PAO1 with a mucA22 mutation, similar to FRD1, causing constitutive
alginate production. MH-S macrophages were cultured with FRD1, PAO1, or PDO300
for 1 hour. After treatment with gentamicin, colony counts were performed to determine
the amount of phagocytosis (Figure 12). As with FRD1, Alg+ PDO300 was phagocytized
significantly less than Alg- PAO1. Therefore, the inhibitory effect of alginate production
on phagocytosis is not limited to the FRD strain.
Taken together, this data is the first to demonstrate that alginate production by P.
aeruginosa has the potential to significantly inhibit phagocytosis by both human and
murine macrophages, in opsonic and non-opsonic conditions.
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Figure 11. Percentage of MH-S macrophages that have phagocytized bacteria
after 30 minutes in the presence of 0.5% human serum. MH-S macrophages were
infected with GFP-expressing FRD, FRD1131, or HfrH for 30 minutes in the presence of
0.5% human serum. Percent phagocytosis indicates the percent of macrophages that
are associated with GFP-expressing bacteria as detected by flow cytometry. Opsonic
phagocytosis of FRD1 was significantly inhibited compared to FRD1131. Data are
shown as mean and standard deviation of three separate experiments. Statistical
significance is determined by Students t-Test (*; P < 0.05, **; P < 0.01, ***; P < 0.001).
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Figure 12. Number of PAO1 or PDO300 phagocytized by MH-S macrophages after
1 hour. MH-S macrophages were infected with FRD1 (Alg+), PAO1 (Alg-), or PDO300
(Alg+) for 1 hour. CFU indicates the number of colony-forming units recovered from
macrophages. Phagocytosis of PDO300 was significantly inhibited compared to PAO1.
Data are shown as mean and standard deviation of a representative triplicate
experiment. Statistical significance is determined by Students t-Test (*; P < 0.05, **; P <
0.01, ***; P < 0.001).
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Chapter 4
Additional Mediators of Phagocytosis of Pseudomonas aeruginosa

The role of LPS on the phagocytosis of Pseudomonas aeruginosa
Figure 12 indicates that while alginate production by the PAO strain significantly
decreased phagocytosis, it did not reduce it to the level of FRD1. Therefore there must
be an additional factor, or factors, inhibiting phagocytosis. Like many CF-adapted
strains, FRD1 has a mutation that blocks the production of O-side chains on LPS, which
are present in PAO. To explore the role of differing LPS structures in the phagocytosis
of P. aeruginosa, strain FRD1810 was compared to FRD1. FRD1810 is a FRD1
recombinant in which LPS O-side chain production has been restored. MH-S
macrophages were cultured with Alg+ FRD1 or Alg+ FRD1810 for 1 hour. After treatment
with gentamicin, colony counts were performed to determine the amount of
phagocytosis (Figure 13). Restored O-side chain production resulted in the
phagocytosis of significantly more FRD1810 than FRD1. This indicated that LPS was
able to have some effect on phagocytosis in the presence of alginate.
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Figure 13. Number of FRD1 or FRD1810 phagocytized by MH-S macrophages after
1 hour. MH-S macrophages were infected with FRD1 (Alg+) or FRD1810 (Alg+) for 1
hour. CFU indicates the number of colony-forming units recovered from macrophages.
Phagocytosis of FRD1810 was significantly increased compared to FRD1. Data are
shown as mean and standard deviation of a representative triplicate experiment.
Statistical significance is determined by Students t-Test (*; P < 0.05, **; P < 0.01, ***; P
< 0.001).
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The role of motility and flagellum on the phagocytosis of Pseudomonas
aeruginosa
It has been reported that both flagellum and motility are critical for promoting the
phagocytosis of P. aeruginosa (1, 47, 50, 51). To ensure that the inhibitory effects of
alginate production on phagocytosis are not due to changes in motility, a motility assay
was used. Soft agar plates, which allow for the movement of motile bacteria, were used
to measure motility. Each plate was inoculated with a log phase culture of FRD1,
FRD1131, FRD1131C’, PAO1, or HfrH and, after incubation, the diameter of the
resulting growth was measured (Figure 14). All FRD strains tested had similar, minimal
growth compared to the motile E. coli strain HfrH, indicating non-motility for all strains.
Non-motility of these FRD strains was also visually confirmed by microscopy.
It is possible that flagellum is expressed by P. aeruginosa despite being nonmotile and this expression could enhance phagocytosis. To address this, flagellum
mutants were constructed for FRD1, FRD1131, and PAO1 and phagocytosis
experiments were repeated using these strains (Figure 15). PAO1flg- was phagocytized
significantly less than PAO1. Likewise, FRD1flg- was phagocytized significantly less
than FRD1, suggesting the presence of flagellum on FRD1. Surprisingly, phagocytosis
of FRD1131flg- was significantly increased relative to FRD1131. This is possibly due to
the one or more stimulatory genes being introduced in the process of disabling flagellum
expression. Conversely, it is possible that an inhibitory gene was disrupted in the
process. The presence of flagellum does appear to affect the phagocytosis of P.
aeruginosa, however, the contribution of flagellum to the phagocytosis of FRD1131 is
not yet known.

58

59

Figure 14. Growth diameter of bacteria in 0.5% agar plates. 0.5% agar plates were
inoculated with FRD1, FRD1131, FRD1131C’, PAO1, or HfrH and incubated at 37°C
overnight. The diameter of the resulting growth was measured. FRD1, FRD1131, and
FRD1131C’ demonstrated a significant lack of motility relative to the motile PAO1 and
HfrH. Data are shown as mean and standard deviation of three separate experiments.
Statistical significance is determined by Students t-Test (*; P < 0.05, **; P < 0.01, ***; P
< 0.001).
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Figure 15. Number of bacteria with and without flagellum phagocytized by MH-S
macrophages. MH-S macrophages were infected with FRD1, FRD1131, PAO1, and
corresponding Flg- mutants for 1 hour. CFU indicates the number of colony-forming
units recovered from macrophages. Phagocytosis of FRD1 and PAO1 Flg- mutants was
significantly decreased. Phagocytosis of FRD1131 Flg- was significantly increased
compared to FRD1131. Data are shown as mean and standard deviation of a
representative triplicate experiment. Statistical significance is determined by Students tTest (*; P < 0.05, **; P < 0.01, ***; P < 0.001).
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Chapter 5
Local Alginate Production is Required to Inhibit Phagocytosis

Exogenous alginate is unable to inhibit phagocytosis of non-mucoid
Pseudomonas aeruginosa by murine macrophages
To begin to understand the role of alginate in the inhibition of phagocytosis I next
determined if the addition of exogenous alginate would protect FRD1131 from
phagocytosis. Previous publications have suggested that exogenous alginate may
protect planktonic and biofilm P. aeruginosa (46, 68). Alginate was isolated from FRD1
and its concentration determined. MH-S macrophages were cultured with FRD1131 in
the presence of increasing concentrations of FRD1 alginate (Figure 16). The addition of
FRD1 alginate did not protect FRD1131 from phagocytosis. It is unlikely that alginate is
inducing an inhibitory signal within the macrophages; as such an effect would still be
possible from exogenous alginate. Instead, it is possible that alginate is preventing an
interaction between the macrophage and P. aeruginosa. Surprisingly, the addition of
200 µg/ml of FRD1 alginate significantly increased phagocytosis of FRD1131. This is
likely due to LPS contamination of the alginate during the isolation procedure.
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Figure 16. Percentage of MH-S macrophages that have phagocytized FRD1131
after 30 minutes in the presence of FRD1 alginate. MH-S macrophages were
infected with GFP-expressing FRD1 or FRD1131 for 30 minutes with increasing
concentrations of FRD1 alginate. Percent phagocytosis indicates the percent of
macrophages that are associated with GFP-expressing bacteria as detected by flow
cytometry. Phagocytosis of FRD1131 (Alg-) was not significantly inhibited with the
addition of FRD1 alginate. Data are shown as mean and standard deviation of three
separate experiments. Statistical significance is determined by Students t-Test (*; P <
0.05, **; P < 0.01, ***; P < 0.001).
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To determine if LPS contamination could be responsible for the enhanced
phagocytosis seen in Figure 16, the experiment was repeated using seaweed alginate.
Although seaweed alginate is free from LPS contamination, it is not acetylated like
FRD1 alginate. Again, an increasing concentration of alginate was added with FRD1131
to MH-S macrophages (Figure 17). As with FRD1 alginate, seaweed alginate was
unable to protect FRD1131 from phagocytosis. The enhanced phagocytosis observed
when using FRD1 alginate was eliminated with the use of seaweed alginate suggesting
that LPS contamination was likely the cause of the additional stimulation.

Mucoid Pseudomonas aeruginosa is unable to protect non-mucoid Pseudomonas
aeruginosa from phagocytosis by murine macrophages
Since exogenous alginate was unable to protect P. aeruginosa from
phagocytosis, my hypothesis was that the alginate produced by FRD1 would not protect
FRD1131 from phagocytosis. FRD1 and FRD1131 were added either individually or
together to MH-S macrophages for 1 hour. After treatment with gentamicin, colony
counts were performed to determine the amount of phagocytosis (Figure 18). FRD1 and
FRD1131 have visually distinct colony morphologies allowing for each strain to be
distinguished from the other when a mixed culture was used. When both strains were
added to macrophages together there was no significant difference between the amount
of phagocytosis of FRD1131, when mixed with FRD1, compared to FRD1131 alone.
Alginate production by FRD1 was unable to inhibit the phagocytosis of FRD1131
suggesting that alginate only benefits the individual bacteria that produced it. Likewise,
FRD1 was phagocytized equally regardless of the presence of FRD1131.
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Figure 17. Percentage of MH-S macrophages that have phagocytized FRD1131
after 30 minutes in the presence of seaweed alginate. MH-S macrophages were
infected with GFP-expressing FRD1131 for 30 minutes with increasing concentrations of
seaweed alginate. Percent phagocytosis indicates the percent of macrophages that are
associated with GFP-expressing bacteria as detected by flow cytometry. Phagocytosis
of FRD1131 (Alg-) was not significantly inhibited with the addition of seaweed alginate.
Data are shown as mean and standard deviation of three samples. Statistical
significance is determined by Students t-Test (*; P < 0.05, **; P < 0.01, ***; P < 0.001).
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Figure 18. Number of FRD1 or FRD1131 phagocytized by MH-S macrophages after
1 hour when infected separately or together. MH-S macrophages were infected with
FRD1 (Alg+), FRD1131 (Alg-), or both strains combined for 1 hour. CFU indicates the
number of colony-forming units recovered from macrophages. Phagocytosis of
FRD1131 was not significantly inhibited by the addition of FRD1. Data are shown as
mean and standard deviation of three separate experiments. Statistical significance is
determined by Students t-Test (*; P < 0.05, **; P < 0.01, ***; P < 0.001).
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Chapter 6
Alginate Confers Protection to Pseudomonas aeruginosa by Blocking
Important Phagocytosis Receptors and Inhibiting Binding

Alginate inhibits phagocytosis of Pseudomonas aeruginosa by murine
macrophages by reducing binding
The first step in phagocytosis is the binding of bacterial ligands to receptors on
the macrophage surface. Since exogenous alginate and alginate produced in a mixed
culture were unable to inhibit phagocytosis this suggests that alginate must be present
on the surface of P. aeruginosa to inhibit phagocytosis. It is possible that alginate on the
bacterial surface could interfere with binding to the macrophage. To assess binding,
cytochalasin D was used to inhibit actin polymerization and therefore prevent
phagocytosis. Various strains were added to MH-S macrophages in the presence of
cytochalasin D for 1 hour. After incubation, macrophages were washed to remove
unbound bacteria and lysed to free any bound bacteria (Figure 19). Alg+ strains FRD1
and FRD1131C’ were bound significantly less than the non-mucoid FRD1131,
suggesting that alginate production does significantly inhibit binding to macrophages.
Taken together, these results show that alginate inhibits phagocytosis by locally
reducing binding to the macrophage. Alginate only protects the bacterium that produced
it and the inhibition of phagocytosis is not due to the presence of alginate in the media.
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Figure 19. Number of bacteria bound to MH-S macrophages after 1 hour in the
presence of cytochalasin D. MH-S macrophages were infected with FRD1 (Alg+),
FRD1131 (Alg-), or FRD1131C’ (Alg+) for 1 hour in the presence of cytochalasin D to
inhibit phagocytosis. CFU indicates the number of colony-forming units recovered from
macrophages. Binding of FRD1 and FRD1131C’ was significantly inhibited compared to
FRD1131. Data are shown as mean and standard deviation of a representative triplicate
experiment. Statistical significance is determined by Students t-Test (*; P < 0.05, **; P <
0.01, ***; P < 0.001).
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Mucoid Pseudomonas aeruginosa induces lipid raft formation in murine
macrophages
Lipid raft formation is important for the phagocytosis of P. aeruginosa, and it is
possible that alginate inhibits lipid raft formation (37). To assess lipid raft formation, MHS macrophages were serum starved for 6 hours and stained with Alexa488-cholera
toxin B to visualize lipid rafts within the macrophage membrane. Cholera toxin B is an
effective stain because it binds to ganglioside GM1 within lipid rafts (23). Macrophages
were then cultured with mCherry-expressing P. aeruginosa for 30 minutes and
visualized by confocal microscopy (Figure 20). Compared to the uninfected control, both
FRD1 and FRD1131 induced lipid raft formation in the macrophages. However,
FRD1131 (Alg-) showed qualitatively more lipid raft staining. A decrease in lipid raft
formation may contribute to the reduced binding demonstrated in Figure 19.
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Figure 20. Confocal images showing rested MH-S macrophages labeled with
cholera toxin interacting with FRD1 or FRD1131. Serum starved MH-S macrophages
were stained with Alexa488 labeled cholera toxin B (green) which binds to ganglioside
GM1, to label lipid rafts. Macrophages were infected with mCherry-expressing FRD1 or
FRD1131 (red) for 30 minutes. Compared to uninfected, resting macrophages both
FRD1 (Alg+) and FRD1131 (Alg-) were able to induce lipid raft formation. However, the
Alg- strain showed qualitatively more lipid raft staining.
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CD11b and CD14 are important in the phagocytosis of Pseudomonas aeruginosa
by murine macrophages and their binding is likely blocked by alginate
My previous studies indicated that alginate production decreased binding of P.
aeruginosa to murine macrophages with a trend towards reduced lipid raft formation.
This is possibly due to blocking specific receptor(s) critical to phagocytosis. The cell
surface receptors CD11b (CR3) and CD14 have both been shown to be important for
the phagocytosis of P. aeruginosa by macrophages and dendritic cells (29). To address
the hypothesis that alginate interferes with receptor activation, I investigated how
alginate affects interaction between P. aeruginosa and CD14 and CD11b. To determine
if CD11b and CD14 are critical to the phagocytosis of mucoid and non-mucoid CF
strains, MH-S macrophages were pretreated with specific blocking antibodies or an
isotype control. Following antibody treatment, FRD1 or FRD1131 were added for 1
hour. After treatment with gentamicin, colony counts were performed to determine the
amount of phagocytosis (Figure 21). When pretreated with α-CD11b or α-CD14,
phagocytosis of FRD1131 was significantly inhibited but not entirely blocked.
Phagocytosis of FRD1 was not inhibited further by the addition of receptor blocking
antibodies, suggesting that these receptors may already be blocked by alginate. While
these results do confirm the importance of CD11b and CD14 in the phagocytosis of
FRD, this does not rule out the involvement of additional receptors for phagocytosis.
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Figure 21. Number of FRD1 or FRD1131 phagocytized by MH-S macrophages in
the presence of CD11b, CD14, or isotype-control blocking antibodies. MH-S
macrophages were infected with FRD1 (A) or FRD1131 (B) for 1 hour in the presence of
CD11b or CD14 blocking antibodies. CFU indicates the number of colony-forming units
recovered from macrophages. Both antibodies significantly inhibited phagocytosis of
FRD1131 compared to the isotype control. However, phagocytosis of FRD1 was not
significantly inhibited by either antibody. Data are shown as mean and standard
deviation of a representative triplicate experiment. Statistical significance is determined
by Students t-Test (*; P < 0.05, **; P < 0.01, ***; P < 0.001).
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To determine if additional receptors are involved in the phagocytosis of FRD
CD11b and CD14 blocking antibodies were used together (Figure 22). Interestingly,
while each antibody alone was able to inhibit phagocytosis of FRD1131 in Figure 21,
the combination of these two antibodies significantly enhanced phagocytosis of both
FRD1 and FRD1131. It is possible that by blocking both receptors, there is a synergistic
signaling response that enhances phagocytosis.
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Figure 22. Number of FRD1 or FRD1131 phagocytized by MH-S macrophages in
the presence of CD11b and CD14, or isotype-control blocking antibodies. MH-S
macrophages were infected with FRD1 (A) or FRD1131 (B) for 1 hour in the presence of
CD11b and CD14 blocking antibodies. CFU indicates the number of colony-forming
units recovered from macrophages. When treated with both antibodies together,
phagocytosis of FRD1 and FRD1131 was significantly increased compared to the
isotype controls. Data are shown as mean and standard deviation of three samples.
Statistical significance is determined by Students t-Test (*; P < 0.05, **; P < 0.01, ***; P
< 0.001).
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Chapter 7
Alginate Inhibits the Activation of Critical Phagocytic Signaling
Pathways

Intracellular signaling of murine macrophages is delayed and reduced by mucoid
Pseudomonas aeruginosa
It is possible that as a result of alginate inhibiting the binding of P. aeruginosa to
macrophages, downstream signaling was affected. Previous studies have implicated
both the PI3K and MAPK pathways in phagocytosis (37). Furthermore, CD11b and
CD14 can contribute to PI3K signaling (54, 76, 80). To determine if alginate expression
interferes with activation of signaling pathways involved in phagocytosis, the effect of
FRD1 and FRD1131 on phosphorylation of AKT and ERK was determined. Alg+ FRD1
and Alg- FRD1131 were incubated with MH-S macrophages for various time points up
to 1 hour. Cell lysates were prepared and activation of AKT was assessed by Western
blot (Figure 23). FRD1131 induces p-AKT in MH-S as early as 15 minutes post infection
whereas FRD1-induced activation is delayed to 30 minutes. The duration of AKT
activation is also significantly lower with FRD1 compared to FRD1131 activated
macrophages which maintained activation at 60 minutes post infection. Alginate
production modulates AKT activation in MH-S macrophages and may contribute to the
inhibition of phagocytosis that is observed.
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Figure 23. Western blot indicating p-AKT and total AKT from MH-S macrophages
after phagocytosis of FRD1 or FRD1131. Serum starved MH-S macrophages were
infected with FRD1 (Alg+) or FRD1131 (Alg-) for up to 1 hour. Cell lysates were collected
and a Western blot was performed using anti-p-AKT and anti-pan-AKT antibodies.
FRD1 infection resulted in delayed AKT activation at 30 minutes compared to 15 minute
activation with FRD1131. Data shown is a representative triplicate experiment.
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In addition to AKT, ERK activation was also assayed by Western blot. Similarly to
AKT activation, infection with FRD1 resulted in delayed and decreased ERK activation
compared to infection with FRD1131 (Figure 24). While p-ERK was faintly detectable at
30 minutes in the FRD1 samples, FRD1131 induced ERK activation as early as 15
minutes post infection.
Taken together, these results show that alginate production by FRD1 leads to
delayed and depressed activation of key signaling pathways relating to efficient
phagocytosis.

Phagocytosis of Pseudomonas aeruginosa by murine macrophages is dependent
on PI3K, but not MEK, activation
To confirm that AKT and ERK pathways are indeed important for the
phagocytosis of P. aeruginosa by alveolar macrophages, the effect of specific pathway
inhibitors on phagocytosis was evaluated. To confirm that the selected inhibitors
effectively inhibited phosphoinositide 3-kinase (PI3K) and MAPK/ERK kinase (MEK)
activation, MH-S macrophages were pretreated with wortmannin, LY294002, or U0126,
for 30 minutes before the addition of FRD1131 for an additional 30 minutes. Cell lysates
were prepared and activation of AKT and ERK was assessed by Western blot (Figure
25). The PI3K inhibitors, wortmannin and LY294002, successfully inhibited AKT
activation at both concentrations tested. The MEK inhibitor, U0126, was able to inhibit
ERK activation.
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Figure 24. Western blot indicating p-ERK2 and total ERK1/ERK2 from MH-S
macrophages after phagocytosis of FRD1 or FRD1131. Serum starved MH-S
macrophages were infected with FRD1 (Alg+) or FRD1131 (Alg-) for up to 30 minutes.
Cell lysates were collected and a Western blot was performed using anti-p-ERK and
anti-pan-ERK antibodies. FRD1 infection resulted in decreased ERK activation at 30
minutes compared to FRD1131. Data shown is a representative triplicate experiment.
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Figure 25. Western blots showing p-ERK2, total ERK1/ERK2, p-AKT, and total AKT
from MH-S macrophages after phagocytosis of FRD1 or FRD1131 in the presence
of wortmannin, LY294002, or U0126. Serum starved MH-S macrophages were
infected with FRD1131 for 30 minutes in the presence of wortmannin (A), LY294002 (A),
or U0126 (B). Cell lysates were collected and a Western blot was performed using antip-AKT (A), anti-pan-AKT (A), anti-p-ERK (B), and anti-pan-ERK (B) antibodies. Both
wortmannin and LY294002 successfully inhibited AKT activation. Despite low baseline
phosphorylation, U0126 was able to inhibit ERK activation.
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MH-S macrophages were pretreated with wortmannin, LY294002, or U0126, for
30 minutes before the addition of FRD1, FRD1131, or PAO1. After treatment with
gentamicin, colony counts were performed to determine the amount of phagocytosis
(Figure 26). Both of the AKT inhibitors, wortmannin and LY294002, significantly
inhibited phagocytosis of all P. aeruginosa strains tested. However the ERK inhibitor,
U0126, did not inhibit phagocytosis of FRD1, FRD1131, or PAO1.
It is possible that ERK signaling may be dispensable for efficient phagocytosis of
these strains. However, there are additional explanations for this observation. The
threshold for ERK to contribute to phagocytosis could be very low or could be
redundant, as there are many interacting signaling pathways. PI3K, and subsequently
AKT, signaling is likely critical to phagocytosis of P. aeruginosa. Thus, alginate
production by P. aeruginosa leads to reduced binding and depressed PI3K signaling,
leading to inhibited phagocytosis.
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Figure 26. Number of bacteria phagocytized by MH-S macrophages after 1 hour in
the presence of AKT or ERK inhibitors. MH-S macrophages were infected with FRD1
(A), FRD1131 (B), or PAO1 (C) for 1 hour in the presence of wortmannin, LY294002, or
U0126. CFU indicates the number of colony-forming units recovered from
macrophages. Both AKT inhibitors, wortmannin and LY294002, significantly inhibited
phagocytosis of FRD1, FRD1131 and PAO1. However, the ERK inhibitor U0126 was
unable to inhibit phagocytosis of any strain tested. Data are shown as mean and
standard deviation of a representative triplicate experiment. Statistical significance is
determined by Students t-Test (*; P < 0.05, **; P < 0.01, ***; P < 0.001).

93

Acid sphingomyelinase activity in murine macrophages is unaffected by mucoid
Pseudomonas aeruginosa
Increased ceramide concentration within lipid rafts has been implicated as a
critical mediator of phagocytosis of P. aeruginosa by epithelial cells and of latex beads
by murine macrophages (23, 57). Ceramide is produced by acid sphingomyelinase
(ASMase) and ASMase activity is increased during infection (23). However, another
study showed that high ceramide concentration was associated with decreased P.
aeruginosa killing in mice (3). P. aeruginosa LPS-induced Acid sphingomyelinase
activity, and subsequently ceramide concentration, has been shown to be NF-κB
dependent (85). As shown in Figure 23, AKT activation, which leads to NF-κB
activation, is altered in the presence of alginate. Therefore, it is possible for ASMase
activity to be affected by alginate production. To determine ASMase activity, MH-S
macrophages were first serum starved for 6 hours, and then cultured with FRD1,
FRD1131 or PAO1 for 15 minutes. Previous studies have indicated that ASMase activity
peaks around 10 to 20 minutes following infection (23). Cell lysates were generated and
ASMase activity was measured (Figure 27). ASMase activity was not significantly
affected by the addition of P. aeruginosa, or the presence of alginate. Consequently,
ceramide concentrations are likely to be unaffected by the presence of alginate. It is
possible that while ASMase activity is NF-κB dependent, NF-κB may be sufficiently
activated despite reduced AKT signaling.

94

95

Figure 27. Acid sphingomyelinase activity from MH-S macrophages after
phagocytosis for 15 minutes. Serum starved MH-S macrophages were infected with
FRD1, FRD1131, or PAO1 for 15 minutes. Macrophage lysates were collected and
analyzed to determine ASMase activity. No significant difference in ASMase activity was
induced by any strain compared to resting macrophages alone. Data are shown as
mean and standard deviation of three separate experiments. Statistical significance is
determined by Students t-Test (*; P < 0.05, **; P < 0.01, ***; P < 0.001).
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IL-8 production by human macrophages is unaffected by mucoid Pseudomonas
aeruginosa
Cytokine production plays an important role in promoting lung damage in cystic
fibrosis (2, 6, 77). Large amounts of neutrophils traffic to the lung, leading to lung
damage despite their inability to clear the infection. IL-8 is a chemokine produced by
macrophages that functions as a major neutrophil chemoattractant. Mucoid P.
aeruginosa inhibits AKT activation which could affect downstream activation of NF-κB
activation. NF-κB is responsible for IL-8 production, therefore, cytokine production could
be altered in macrophages due to altered binding, and signaling, from the presence of
alginate (88). To determine if IL-8 production was affected by alginate production, an IL8 ELISA kit was used. First, a time course of IL-8 production was established. THP-1
macrophages were cultured with FRD1, FRD1131 or 1 mg/ml zymosan for up to 8
hours. Supernatants were removed at 2 hour intervals and frozen for analysis (Figure
28). At every time point measured, IL-8 induced by FRD1 and FRD1131 appeared
similar.
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Figure 28. Time course of IL-8 produced by THP-1 macrophages after
phagocytosis of FRD1 or FRD1131. THP-1 macrophages were infected with FRD1,
FRD1131, or treated with zymosan for up to 8 hours. Supernatants were collected at
various time points and analyzed by ELISA for IL-8 production. At each point measured,
both FRD1 and FRD1131 induced similar amounts of IL-8.
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To confirm the effect of alginate on the production of IL-8 by THP-1
macrophages, the ELISA was repeated using 8 hour cultures (Figure 29). As indicated,
there was no significant difference in the amount of IL-8 induced by FRD1 compared to
FRD1131. It is possible that the majority of IL-8 produced by macrophages was contact
independent. If this were the case, the inhibited binding due to alginate would not affect
IL-8 production. To determine if contact with P. aeruginosa was necessary for IL-8
production, FRD1 and FRD1131 were cultured in RPMI for 8 hours. After 8 hours
supernatants were collected and applied to THP-1 macrophages for an additional 8
hours. As shown in Figure 29, the P. aeruginosa supernatants were able to induce IL-8
in THP-1 macrophages. There was no significant difference in the amount of IL-8
induced by the supernatants compared to the amount induced by the P. aeruginosa
strains themselves. Therefore IL-8 production by THP-1 macrophages appeared to be
contact independent and was unaffected by the production of alginate.
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Figure 29. Amount of IL-8 produced by THP-1 macrophages 8 hours after
phagocytosis of FRD1, FRD1131, or in the presence of bacterial supernatants.
THP-1 macrophages were infected with FRD1, FRD1131, or treated with FRD1 or
FRD1131 supernatants for 8 hours. Supernatants were collected and analyzed by
ELISA for IL-8 production. No significant difference was found between the amount of
IL-8 induced by FRD1 compared to FRD1131. Similarly, no significant difference was
found between the amount of IL-8 induced by FRD1 and FRD1131 compared to IL-8
induced by the respective supernatants. Data are shown as mean and standard
deviation of three separate experiments. Statistical significance is determined by
Students t-Test (*; P < 0.05, **; P < 0.01, ***; P < 0.001).
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MIP-2 production by murine macrophages is unaffected by mucoid Pseudomonas
aeruginosa
Murine macrophages do not produce IL-8 and instead produce a similar
neutrophil chemoattractant called MIP-2. I next wanted to asses MH-S macrophages for
MIP-2 production in response to FRD1 and FRD1131. MH-S macrophages were
cultured with FRD1 or FRD1131 for 8 hours. After incubation, supernatants were frozen
for analysis by MIP-2 ELISA kit (Figure 30). As with IL-8 production, there was no
significant difference in the amount of MIP-2 produced between FRD1 and FRD1131.
Eight hour supernatants were again tested to determine contact dependence of MIP-2
production. There was no significant difference in MIP-2 production induced by the
supernatants compared to the strains themselves.
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Figure 30. Amount of MIP-2 produced by MH-S macrophages 8 hours after
phagocytosis of FRD1, FRD1131, or in the presence of bacterial supernatants.
MH-S macrophages were infected with FRD1, FRD1131, or treated with FRD1 or
FRD1131 supernatants for 8 hours. Supernatants were collected and analyzed by
ELISA for MIP-2 production. No significant difference was found between the amount of
IL-8 induced by FRD1 compared to FRD1131. Similarly, no significant difference was
found between the amount of IL-8 induced by FRD1 and FRD1131 compared to IL-8
induced by the respective supernatants. Data are shown as mean and standard
deviation of three separate experiments. Statistical significance is determined by
Students t-Test (*; P < 0.05, **; P < 0.01, ***; P < 0.001).
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A possible problem with the use of 8 hour supernatants for an additional 8 hours
is that the soluble, stimulatory factors in the supernatants would be highly concentrated
immediately, whereas the wells with the P. aeruginosa strains added directly would
slowly build up to that high concentration over the 8 hour incubation. As a more direct
assessment of the contact dependence of MIP-2 production, 0.4 µm filter inserts were
used to separate the added P. aeruginosa from the macrophages while allowing for
soluble factors to diffuse throughout the media (Figure 31). There remained no
significant difference in the amount of MIP-2 produced between FRD1 and FRD1131
with, or without, the filter. However, the addition of the filter significantly reduced the
amount of MIP-2 produced by both FRD1 and FRD1131. The filter did not entirely
eliminate MIP-2 production, suggesting that MIP-2 production is partially contact
independent. Furthermore, based on the high concentration supernatants used in
Figure 29 and 30, soluble factors can compensate for the lack of contact.
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Figure 31. Amount of MIP-2 produced by MH-S macrophages 8 hours after
phagocytosis of FRD1, FRD1131, or in the presence of bacterial supernatants
from bacteria separated by a filter. MH-S macrophages were infected with FRD1 or
FRD1131 either directly or above a filter for 8 hours. Supernatants were collected and
analyzed by ELISA for MIP-2 production. No significant difference was found between
the amount of IL-8 induced by FRD1 compared to FRD1131. However, the amount of
IL-8 induced by FRD1 was significantly higher than the amount induced by FRD1 when
separated by a filter. Similarly, the amount of IL-8 induced by FRD1131 was significantly
higher than the amount induced by FRD1131 when separated by a filter. Data are
shown as mean and standard deviation of three separate experiments. Statistical
significance is determined by Students t-Test (*; P < 0.05, **; P < 0.01, ***; P < 0.001).
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Chapter 8
Discussion and Future Studies

The goal of this research was to determine the mechanism by which alginate, an
exopolysaccharide secreted by mucoid Pseudomonas aeruginosa, inhibits phagocytosis
by macrophages. The mucoid phenotype has been shown to enhance survival of P.
aeruginosa and infection of the lung significantly increases the mortality rate of CF
patients (8, 43, 68, 70). Therefore, understanding how alginate protects P. aeruginosa
from phagocytosis is important for the treatment of cystic fibrosis lung infections. To
address my goal, I investigated the effect of alginate by using two cell line models for
phagocytosis. Initially, since cystic fibrosis is a human disease, the human monocytic
cell line THP-1 was used as model for phagocytosis. Since alveolar macrophages have
altered receptor expression, activation and survival compared to peripheral
macrophages, I used the murine alveolar macrophage cell line MH-S to investigate
phagocytosis by macrophages more appropriate to the lung infection environment (25,
56). The FRD strain of P. aeruginosa was used to address the effect of alginate on
phagocytosis by these two cell lines. FRD1 is a mucoid cystic fibrosis clinical isolate and
FRD1131 is a non-mucoid isogenic algD::Tn501-33 mutant. The only difference
between these mutants is the production of alginate which allowed me to study the
effect of alginate on phagocytosis. This research demonstrates for the first time that
alginate on the bacterial surface inhibits phagocytosis by reducing binding to
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macrophages and interfering with important phagocytosis receptors, resulting in
decreased intracellular signaling and reduced phagocytosis.
Previous studies attempted to understand the role of alginate in resisting the
immune response. Several groups suggested that mucoid P. aeruginosa are protected
against non-opsonic phagocytosis (8, 43, 68). Likewise, Leid et al. (46) showed that
mucoid P. aeruginosa have significantly enhanced biofilm survival against opsonic
killing. These publications, however, did not quantitatively address the role of alginate in
the non-opsonic phagocytosis of planktonic P. aeruginosa. My research demonstrates
that alginate production by P. aeruginosa significantly protects against both opsonic and
non-opsonic phagocytosis by human and murine macrophages. Phagocytosis was
assessed through two assays that measured different aspects of phagocytosis. The
total number of bacteria phagocytized was determined by lysing macrophages and
counting CFUs. The fraction of macrophages engaged in phagocytosis was determined
by using flow cytometry. It is also possible to use the mean fluorescence intensity (MFI)
from the flow cytometry data to determine the relative number of GFP-expressing
bacteria phagocytized by each macrophage. However, when performing the
experiments presented here, the MFI data often revealed very little difference amongst
the different strains or the negative control. It is possible that the system is unable to
detect the difference in fluorescence from just a few bacteria. Another explanation could
be that the amount of GFP within each bacterium could be inconsistent, depending on
how long the protein has been expressed by an individual bacterium.
Alginate production and flagellum expression are inversely expressed in P.
aeruginosa. Therefore, when considering the role of alginate in phagocytosis, it is also
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important to consider the role of flagellum (78, 79). Mahenthiralingam et al. (50, 51)
have shown that expression of flagellum significantly enhances phagocytosis by
macrophages and conclude that flagellum is critical to internalization, but not binding.
However, other studies indicated that motility, independent of flagellum expression and
TLR signaling, is responsible for evasion of phagocytosis (1, 47). While I did observe
decreased phagocytosis in the absence of flagellum expression, significant levels of
phagocytosis occur in the absence of flagellum expression and motility. My results
suggest that flagellum is expressed by FRD1, which enhances phagocytosis. This
would mean that despite alginate production, indicating active σ 22 and the down
regulation of flagellum expression, flagellum is expressed enough to enhance
phagocytosis. These results also disagree with the findings by the Berwin lab (1, 47),
which conclude that motility, and not flagellum, is responsible for stimulating
phagocytosis. It is possible that this disagreement is due to differences in the
macrophages and P. aeruginosa strains studied. While this study uses human and
murine macrophages cell lines, their studies used human peripheral blood monocytederived macrophages. Primary human macrophages could express different amounts of
TLR5, which could affect the amount of phagocytosis. For the motility studies, Lovewell
et al. (47) and Amiel et al. (1) both use the P. aeruginosa strain PA14. It is possible that
the expression of ligands involved in phagoytosis, such as pilin or serotypes of LPS,
could account for the observed differences.
Interestingly, when cultured together, alginate produced by FRD1 was unable to
inhibit phagocytosis of non-mucoid FRD1131. This implies that alginate did not induce a
negative signal within the macrophages because the presence of alginate in the media
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would inhibit phagocytosis if this were the case. Also, alginate added exogenously was
unable to protect non-mucoid P. aeruginosa from phagocytosis. Again, this suggests
that alginate is not negatively regulating macrophages or else this would inhibit
phagocytosis of non-mucoid FRD1131. Since alginate decreases P. aeruginosa binding
to murine macrophages it is more likely that alginate interferes with a receptor-ligand
interaction that is necessary for promoting phagocytosis.
In an attempt to identify a receptor(s) that may be blocked by alginate, I
investigated the contribution of CD11b and CD14, which have been reported to facilitate
phagocytosis of P. aeruginosa (29). CR3 has been shown to bind to a number of
ligands associated with P. aeruginosa including LPS, APG, and β-glucan (7, 89).
Blocking either CD11b or CD14 led to a significant decrease in phagocytosis of nonmucoid P. aeruginosa by murine macrophages, but this effect was absent with mucoid
P. aeruginosa. This suggests that both of these receptors were being blocked
completely by alginate and that further blockade with the antibodies was ineffective.
Furthermore, phagocytosis of FRD1 or FRD1131 was not inhibited when both CD11b
and CD14 antibodies were used together. It is possible that the antibodies did not
completely block the receptors. This would allow for some function to remain and allow
for phagocytosis, but this does not explain why phagocytosis was significantly enhanced
when both antibodies were used. It is possible that the combination of antibodies
resulted in stimulating or activating the macrophages. In an infection, it is likely that both
of these receptors, and many others, would be simultaneously stimulated in a pathogen
rich environment.
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I also investigated the effects of alginate on the downstream signaling events
contributing to efficient phagocytosis. Both CD11b and CD14 can activate PI3K and
MEK1/2. CD14/TLR4 signaling through MyD88, IRAK1/4, and TRAF6 activate PI3K and
MEK1/2 (71). CR3 can also lead to PI3K and MEK activation through PLC and protein
kinase C (PKC) (26, 71, 83). AKT and ERK phosphorylation were used to measure
PI3K and MEK1/2 activation. Both ERK and AKT activation were decreased by alginate
production. While PI3K activation was found to be critical for phagocytosis of P.
aeruginosa, loss of MEK activation had no significant effect. Reduced ERK activation by
alginate may lead to altered inflammatory signaling despite not being necessary for
phagocytosis. NF-κB activation occurs downstream of AKT phosphorylation and leads
to ASMase activity (85). However, I found that ASMase activity was not altered in
murine macrophages infected with mucoid P. aeruginosa compared to non-mucoid
strains. This could be due to high ASMase activity in murine macrophages, or that the
cells were not allowed to rest long enough before phagocytosis. In either case the
ASMase activity in the negative control would be higher than expected. Similarly, I
found no significant difference in the amount of IL-8 or MIP-2 induced by mucoid and
non-mucoid P. aeruginosa. This could be because MIP-2 induction was found to be
partially contact-independent, which is often the case in cytokine induction (84). It is
possible that while ASMase activity and IL-8 production are NF-κB dependent, NF-κB
may be sufficiently activated despite reduced AKT signaling. It is also possible that NFκB activity is stimulated through a PI3K-independent pathway. This could be
accomplished through other scavenger and pattern recognition receptor signaling.
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While this dissertation presents many new findings, several avenues of research
remain open relating to the effect of alginate production on phagocytosis. First, the
addition of LPS O-side chain production to the FRD stain (FRD1810) and the addition of
alginate production to the PAO strain (PDO300) do not lead to equal phagocytosis.
Despite both strains producing alginate and LPS containing O-Side chains, PDO300 is
phagocytized significantly more than FRD1810. There may be additional stimulatory
factors present in PDO300, or addition inhibitory factors present in FRD1810, leading to
altered phagocytosis. Further analysis of surface receptors present on both strains
could reveal additional receptors present or lacking in the two strains. Additionally, I
observed a trend of reduced induction of lipid raft formation by Alg+ FRD1 compared to
Alg- FRD1131. While I found no significant difference in the amount of ASMase activity
induced between the two strains, it may be possible to quantify a difference in lipid raft
formation or ceramide concentration. Furthermore, it would be interesting to determine if
actin polymerization, and the formation of the phagocytic cup, is decreased when
phagocytizing mucoid P. aeruginosa. Additionally, Leid et al. (46) established that
alginate production also protects P. aeruginosa in a biofilm from opsonic phagocytosis.
The experiments presented here could be repeated in the context of mucoid and nonmucoid P. aeruginosa in a biofilm (62). Finally, the research presented in this
dissertation has focused on phagocytosis by human and murine macrophage cell lines.
It would be beneficial to extend these studies by using primary human and murine
macrophages. Primary human alveolar macrophages could be isolated from sputum of
healthy donors and cystic fibrosis patients (73). Likewise, bronchoalveolar lavage fluid
(BALF) can be acquired from mice and used to generate primary murine alveolar
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macrophages (65). This would also allow for studies using CFTR knockout mice to
evaluate phagocytosis by CFTR-deficient alveolar macrophages (24). Macrophages
from CD11b and CD14 single, or double knockout mice could also be useful. This would
allow for phagocytosis assays which could identify other important phagocytosis
receptors. Other receptors found this way could again be confirmed by using
macrophages from knockout mice.
Alginate may also relate to the clearance of apoptotic cells. It is possible that
alginate interferes with binding of the lactadherin-phosphatidylserine complex to the
αVβ3 integrin. αVβ3 integrin and CR3 have both been shown to bind HMGB1 (20, 89). It
is conceivable then that if alginate is able to interfere with CR3, as I have shown to be
possible in this study, then it could interfere with αVβ3 integrin as well. By doing so,
alginate would inhibit phagocytic clearance of apoptotic cells (16). Thus, alginate could
exacerbate the ineffective clearance of apoptotic neutrophils in the cystic fibrosis lung.
In summary, this dissertation demonstrated that alginate production by the cystic
fibrosis clinical isolate of Pseudomonas aeruginosa, FRD1, inhibited phagocytosis by
significantly decreasing binding to murine macrophages. Both CD11b and CD14 appear
to be important for phagocytosis and may be blocked by alginate. Decreased binding
leads to reduced downstream mediators of phagocytosis, including decreased AKT and
ERK activation. To have this protective effect, alginate must be produced directly by the
bacteria and did not appear to benefit other local non-mucoid bacteria. Understanding
how alginate protects P. aeruginosa from phagocytosis is important for the treatment of
lung infections commonly found in cystic fibrosis patients. By understanding the
pathways involved in mediating efficient phagocytosis of clinical isolates, it may be
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possible to develop a treatment to promote clearance by the resident alveolar
macrophages. These experiments may also serve as a model to evaluate the
effectiveness of such treatments. This approach also provides valuable insight into
previously unknown macrophage phagocytosis mechanisms.
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